Back to UBS Group AG UBS Group AG

ARTVARTV
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in ARTIVA BIOTHERAPEUTICS INC

Yes. Ubs holds 184,020 shares of ARTV (Artiva Biotherapeutics), worth $1.8M, as of its Q2 2026 13F filing. It increased the position from 1,527 shares in Q1 2026. Ubs has held ARTV in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$1.8M

Current Shares

184,020

Total Value Change

+$1.7M

Total Shares Change

+177,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
184,020
+120x
$1.8M0.0%$9.70
42
2026-Q1
Decreased
1,527
-95.9%
$9,8340.0%$5.47
0
2025-Q4
Increased
36,873
+74.4%
$158,1850.0%$4.18
23
2025-Q3
Increased
21,143
+533.6%
$60,6800.0%$2.92
23
2025-Q2
Decreased
3,337
-92.3%
$5,0390.0%$1.47
0
2025-Q1
Increased
43,077
+21.8%
$129,2310.0%$3.16
18
2024-Q4
Increased
35,379
+434.6%
$356,6200.0%$10.58
38
2024-Q3
New
6,618
-
$102,2480.0%$14.01
33

Other major holders of ARTV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used